Cargando…
BCL2 is a predictive marker of adjuvant CMF regimen in triple-negative breast cancer patients
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3247056/ http://dx.doi.org/10.1186/bcr3029 |
| _version_ | 1782220033639841792 |
|---|---|
| author | Bouchalova, K Cizkova, M Trojanec, R Koudelakova, V Radova, L Furstova, J Melichar, B Cwiertka, K Kharaishvili, G Kolar, Z Hajduch, M |
| author_facet | Bouchalova, K Cizkova, M Trojanec, R Koudelakova, V Radova, L Furstova, J Melichar, B Cwiertka, K Kharaishvili, G Kolar, Z Hajduch, M |
| author_sort | Bouchalova, K |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3247056 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2011 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-32470562011-12-29 BCL2 is a predictive marker of adjuvant CMF regimen in triple-negative breast cancer patients Bouchalova, K Cizkova, M Trojanec, R Koudelakova, V Radova, L Furstova, J Melichar, B Cwiertka, K Kharaishvili, G Kolar, Z Hajduch, M Breast Cancer Res Poster Presentation BioMed Central 2011 2011-11-16 /pmc/articles/PMC3247056/ http://dx.doi.org/10.1186/bcr3029 Text en Copyright ©2011 Bouchalova et al. |
| spellingShingle | Poster Presentation Bouchalova, K Cizkova, M Trojanec, R Koudelakova, V Radova, L Furstova, J Melichar, B Cwiertka, K Kharaishvili, G Kolar, Z Hajduch, M BCL2 is a predictive marker of adjuvant CMF regimen in triple-negative breast cancer patients |
| title | BCL2 is a predictive marker of adjuvant CMF regimen in triple-negative breast cancer patients |
| title_full | BCL2 is a predictive marker of adjuvant CMF regimen in triple-negative breast cancer patients |
| title_fullStr | BCL2 is a predictive marker of adjuvant CMF regimen in triple-negative breast cancer patients |
| title_full_unstemmed | BCL2 is a predictive marker of adjuvant CMF regimen in triple-negative breast cancer patients |
| title_short | BCL2 is a predictive marker of adjuvant CMF regimen in triple-negative breast cancer patients |
| title_sort | bcl2 is a predictive marker of adjuvant cmf regimen in triple-negative breast cancer patients |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3247056/ http://dx.doi.org/10.1186/bcr3029 |
| work_keys_str_mv | AT bouchalovak bcl2isapredictivemarkerofadjuvantcmfregimenintriplenegativebreastcancerpatients AT cizkovam bcl2isapredictivemarkerofadjuvantcmfregimenintriplenegativebreastcancerpatients AT trojanecr bcl2isapredictivemarkerofadjuvantcmfregimenintriplenegativebreastcancerpatients AT koudelakovav bcl2isapredictivemarkerofadjuvantcmfregimenintriplenegativebreastcancerpatients AT radoval bcl2isapredictivemarkerofadjuvantcmfregimenintriplenegativebreastcancerpatients AT furstovaj bcl2isapredictivemarkerofadjuvantcmfregimenintriplenegativebreastcancerpatients AT melicharb bcl2isapredictivemarkerofadjuvantcmfregimenintriplenegativebreastcancerpatients AT cwiertkak bcl2isapredictivemarkerofadjuvantcmfregimenintriplenegativebreastcancerpatients AT kharaishvilig bcl2isapredictivemarkerofadjuvantcmfregimenintriplenegativebreastcancerpatients AT kolarz bcl2isapredictivemarkerofadjuvantcmfregimenintriplenegativebreastcancerpatients AT hajduchm bcl2isapredictivemarkerofadjuvantcmfregimenintriplenegativebreastcancerpatients |